These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6449829)

  • 1. Activation of factor XII in plasma from rats pretreated with tranexamic acid. Inhibition of a plasmin-induced loss of the functional activity of high molecular weight kininogen.
    Briseid K; Ryssdal AB
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):161-70. PubMed ID: 6449829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of factor XII in rat plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):43-51. PubMed ID: 6175175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of plasma kallikrein and a kallikrein-like plasminogen activator generated by acetone in rat plasma.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):371-80. PubMed ID: 6554030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
    Chan JY; Movat HZ; Burrowes CE
    Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
    [No Abstract]   [Full Text] [Related]  

  • 10. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of t-AMCHA and EACA on the plasma kallikrein system.
    Nakahara M
    Thromb Haemost; 1977 Feb; 37(1):104-10. PubMed ID: 576509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
    Iwamoto M
    Thromb Diath Haemorrh; 1975 Jun; 33(3):573-85. PubMed ID: 125463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
    Kleniewski J; Donaldson VH
    J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cofactor function of human high molecular weight kininogen induced by rat plasma kallikrein.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1985 Jul; 57(1):47-52. PubMed ID: 3850711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
    Takada A; Takada Y
    Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):25-32. PubMed ID: 6431752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.